
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated March 31, 2025, titled "Press Release about submission of IND Application for SBO-154 to USFDA".
Filed with NSE ·

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated March 31, 2025, titled "Press Release about submission of IND Application for SBO-154 to USFDA".
6ix hasn’t read this filing yet.
Sun Pharma Advanced Research Co. Ltd. on 6ix
Follow Sun Pharma Advanced Research into a list and get an email when it puts out news.
Follow Sun Pharma Advanced Research